MARK RICHARD J sold $2.6M of THC

MARK RICHARD J sold 10,000 shares of TENET HEALTHCARE CORP (THC) at $263.42 ($2.63M total) on 2026-09-10.

Original reporting
SEC EDGAR · MARK RICHARD J
Published Sep 15, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 12:38 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$THC
Bearish
medium confidence
Mentioned
$THC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCBearishLow
01

Why it matters

Provides transparency on insider holdings; modest sell may slightly affect sentiment.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential tax planning or portfolio rebalancing could be driving the sale, not company outlook.

Relevance 6/10Novelty 4/10Timing: filed after market on 2026-09-14

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$THCBearishMedium confidence
Context

Director Mark Richard J sold 10,000 shares of Tenet Healthcare for $2.63M, reducing his stake to 25,121 shares.

Expected impact

Potential slight dip in THC price, likely within normal volatility range.

Evidence & confidence

Director sales are monitored by traders; however, the $2.6M size is modest relative to market cap, limiting impact.

Market effects

Minimal effect on healthcare sector; insider sales are routine.

No significant regional impact.

Limited to investors tracking Tenet Healthcare.

Counterpoint

The sale could be unrelated to company fundamentals and may not indicate future performance.

Key entities

  • Tenet Healthcare Corp.

    US-listed healthcare services provider (ticker THC).

  • Mark Richard J

    Director of Tenet Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.